Fig. 13From: In-silico design and evaluation of an epitope-based serotype-independent promising vaccine candidate for highly cross-reactive regions of pneumococcal surface protein Aa Evaluation of cross-reactivity of anti-PspA1-5c+p antibody using the Whole-cell ELISA. b The binding ability of anti-PspA1-5c+p IgG against the surface of three pneumococcus strains, representing two families of PspA as cross-reactivity response. The error bar is representative of the mean ± standard deviationBack to article page